Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Sundeep Kasi (NPI 1952697773)

Field	Value
Entity Type	Individual
Organization	Sundeep Kasi
Address	6354 Walker Ln Fl 1
City	Alexandria
State	VA
ZIP	22310
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 20, 2011

Payer Source	Total Paid
Medicare	$4.1M
Medicaid	$0

Key Findings

This provider’s billed activity is dominated by Medicare: lifetime Medicare revenue is $4.1M while there is no Medicaid billing on file, making the practice effectively single‑payer (Medicare) in scale and exposure. The absence of Medicaid revenue reduces payer diversification and concentrates reimbursement risk on Medicare policy and pricing for retina services.

Revenue is highly concentrated in a small set of drug administration codes: the precomputed top 3 Medicare codes account for 66.8% of total Medicare revenue, driven primarily by J0178 ($1.7M, 42.1%), J2777 ($683.8K, 16.7%), and J3490 ($326.9K, 8.0%). This concentration indicates the practice derives the majority of its Medicare dollars from intravitreal pharmacologic therapies and related drug billing.

The code mix and top-line codes indicate a retina-focused, injection‑centric practice model: J0178 (aflibercept) and J2777 (faricimab) are the largest revenue contributors and 67028 (intravitreal injection) also appears among top codes, which together point to frequent outpatient intravitreal therapy. High utilization of diagnostic imaging codes such as 92134 (3.4K claims, $116.6K revenue) further supports a service line centered on active medical retina management with surveillance imaging.

Several codes show exceptional volumes relative to national peers for non-drug services: 92014 (2.8K claims, $279.6K revenue) ranks in the 100th percentile and is labeled an “extreme outlier,” while 92134 (3.4K claims) and 92202 (1.8K claims) are 99th and 98th percentile “extreme outlier” volumes respectively. These elevated ranks for comprehensive established exams and retinal diagnostic procedures indicate the provider sees substantially more follow-up and imaging encounters per Medicare than typical peers.

On competitive standing for high-revenue drugs, the provider ranks above many peers but is not uniquely dominant: J0178 ranks #318 of 3204 providers (90th percentile), J2777 ranks #426 of 2039 (79th percentile), and J3490 ranks #391 of 2838 (86th percentile). In plain terms, the practice is an above‑average national participant for its top drug therapies but operates among many other sizable retina providers rather than as a sole market leader.

Unclassified and specialty biologic codes contribute meaningful, high‑cost per‑claim revenue: J3490 shows 177 claims with an $1847 avg paid/claim ($326.9K revenue, 8.0% of Medicare revenue) and J3590 shows 78 claims with a $2505 avg paid/claim ($195.4K, 4.8%). These lines suggest episodic high-dollar items beyond standard vialized anti‑VEGF billing that can materially affect revenue volatility and payer review focus.

The provider has an established NPI tenure — enumerated 2011-06-20 (~15 years ago) — indicating a sustained clinical presence in the market. Combined with $4.1M in lifetime Medicare revenue and persistent high volumes in both injections and imaging, this tenure supports a stable, dedicated retina practice rather than a newly established entrant.

From a business risk/opportunity perspective, heavy dependence on a small group of intravitreal drug codes (top 3 = 66.8% of Medicare revenue) creates sensitivity to shifts in drug utilization, biosimilar adoption, or Medicare reimbursement changes; conversely, the high volumes of established visits and imaging (92014, 92134, 92202 as extreme outliers) represent an operational strength that could be leveraged to expand non‑drug service lines or negotiate coverage arrangements.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,520	$680	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	23,580	$30	$683.8K
J3490	Unclassified drugs	180	$1,850	$326.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,770	$100	$279.6K
J2778	Injection, ranibizumab, 0.1 mg	1,160	$190	$218.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,990	$110	$210.9K
J3590	Unclassified biologics	80	$2,510	$195.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,080	$120	$129.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,430	$30	$116.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	300	$220	$63.4K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Sundeep Kasi — 3 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	20	80	1,400	$690	$1.1M
J2777	16	60	13,200	$30	$517.1K
J2778	10	40	560	$180	$171.5K
J3590	3	20	40	$2,290	$126K
67028	18	90	1,000	$90	$107.1K
J2781	4	20	560	$120	$86.6K
Q5128	3	10	190	$220	$70.7K
J7312	5	20	240	$160	$42.5K
92014	8	870	170	$80	$32.8K
J3490	5	110	60	$280	$20.5K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Sundeep Kasi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Alok Bansal	CA	Ophthalmology Physician	$3M	$4.7M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Omesh Gupta	PA	Ophthalmology Physician	$7.1M	$80
Mitchell Fineman	PA	Ophthalmology Physician	$7M	$0
Richard Kaiser	PA	Ophthalmology Physician	$6.6M	$0
Carl Regillo	PA	Ophthalmology Physician	$6.5M	$0
Allen Ho	PA	Ophthalmology Physician	$6.4M	$0
James Vander	PA	Ophthalmology Physician	$6.3M	$0
Marc Spirn	PA	Ophthalmology Physician	$6.3M	$0

Nearby Providers

Other providers in the same ZIP code as Sundeep Kasi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Reshma Katira	VA	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Franconia-springfield Surgery Center, LLC	VA	Ambulatory Surgical Clinic/Center	$1.6M	$275.4K
Simon Fishman	VA	Specialist	$624K	$0
Michael Abidin	VA	Otolaryngology/Facial Plastic Surgery Physician	$439.2K	$0
Thomas Martinelli	VA	Orthopaedic Surgery Physician	$296.7K	$0
Peter Thomas	VA	Surgery of the Hand (Surgery) Physician	$157.7K	$0
Daniel Weingold	VA	Orthopaedic Surgery Physician	$154.1K	$0
Yvette Appiah	VA	Dermatology Physician	$136.2K	$0
Iyad Saidi	VA	Otolaryngic Allergy Physician	$124.6K	$0

Sundeep Kasi — Billing Profile & Reimbursement Data

Sign up for Sundeep Kasi — Billing Profile & Reimbursement Data policy alerts

Sundeep Kasi — Billing Profile & Reimbursement Data

Sign up for Sundeep Kasi — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References